Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology)
Diabetologist
M.B.B.S., MPhill (Bio-Chemistry), PhD
Diabetologist
M.B.B.S, F.C.P.S. (Medicine) , MD (USA)
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, M.R.C.P (UK), M.D (US)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), M.C.P.S
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
General Physician
M.B.B.S., D.D.E, C.D.M
Internal Medicine Specialist
M.B.B.S., F.C.P.S (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures